Influenza Vaccines: From Surveillance Through Production to Protection
- 1 March 2010
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 85 (3) , 257-273
- https://doi.org/10.4065/mcp.2009.0615
Abstract
No abstract availableKeywords
This publication has 216 references indexed in Scilit:
- Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responsesThe Lancet Infectious Diseases, 2009
- Self-reported influenza vaccination rates among health care workers in a large health systemAmerican Journal of Infection Control, 2008
- Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected childrenVaccine, 2008
- Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platformVaccine, 2008
- Vaccines for preventing influenza in healthy childrenPublished by Wiley ,2008
- Prevention of Antigenically Drifted Influenza by Inactivated and Live Attenuated VaccinesNew England Journal of Medicine, 2006
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004
- A “universal” human influenza A vaccineVirus Research, 2004
- RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in childrenThe Lancet, 1998
- Antibody response of pediatric solid organ transplant recipients to immunization against influenza virusThe Journal of Pediatrics, 1995